Filing Details
- Accession Number:
- 0000899243-19-018747
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-01 20:26:19
- Reporting Period:
- 2019-06-27
- Accepted Time:
- 2019-07-01 20:26:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1771917 | Karuna Therapeutics Inc. | KRTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1237564 | M Steven Paul | C/O Karuna Therapeutics, Inc. 33 Arch Street, Suite 3110 Boston MA 02110 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-06-28 | 6,800 | $22.86 | 6,800 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-28 | 3,200 | $23.43 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-06-27 | 616,703 | $0.00 | 616,703 | $16.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-06-28 | 71,121 | $0.00 | 71,121 | $20.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 616,703 | 2019-06-27 | No | 4 | A | Direct | |
| 71,121 | 2019-06-28 | No | 4 | A | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.31 to $23.21, inclusive. The reporting person undertakes to provide to Karuna Therapeutics, Inc., any security holder of Karuna Therapeutics, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.35 to $23.48, inclusive. The reporting person undertakes to provide to Karuna Therapeutics, Inc., any security holder of Karuna Therapeutics, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- At time of each grant, 65% of the shares underlying the grant were vested, with the remaining vesting in equal monthly installments through June 15, 2021.
Billionaire Hedge Funds
